Strategic expansion LIC is expanding facilities across Hamilton, Australia, and New Zealand, signaling growing demand for diagnostics and gene testing capabilities. This creates opportunities to offer scalable lab services, genetics workflows, and software integrations to support new sites and regional teams.

Genetics and health With investments in GeneMark and animal health testing, LIC prioritizes advanced genetics and health diagnostics. Sales potential exists for enhanced genomics services, data analytics platforms, and predictive health tools that can be deployed across their farming network.

R&D leadership LIC allocates over 5 percent of revenue to R&D, well above sector averages, indicating a strong appetite for innovative solutions. This supports partnerships around new breeding technologies, AI-driven herd management, and collaborative innovation programs.

People strategy Leadership hiring and a focus on people, including a new Chief People Officer, suggest ongoing workforce initiatives. Opportunities may include employee-focused platforms, training, change management services, and talent analytics to optimize performance and adoption of tech solutions.

Collaborative growth Historical partnerships with breed associations and joint initiatives (Discovery Project, Synergizer) show LIC openness to co-development. This presents avenues for co-branded products, joint go-to-market programs, and ecosystem partnerships to expand reach in dairy genetics and herd improvement.